Robust angiogenic properties of cultured human peripheral blood-derived CD31+ cells

International Journal of Cardiology

Volumn 166, Issue 3, 2013, Pages 709-715

  Kim, Moo Hyun ^a,b   Jin, Enze ^c   Zhang, Hong Zhe ^a,b   Kim, Sung Whan ^a,b  

^a Dong A University College of Medicine   (South Korea)

^b Dong A University   (South Korea)

^c HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Angiogenesis; CD31; Ischemia; Transplantation

Indexed keywords

ANGIOGENIC FACTOR; CD31 ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIANGIOGENIC ACTIVITY; ARTICLE; BLOOD PERFUSION; CAPILLARY DENSITY; CD31+ T LYMPHOCYTE; CELL CULTURE; CELL ISOLATION; CELL TRANSPLANTATION; COLONY FORMING CELL; CONTROLLED STUDY; FEMORAL ARTERY; GENE EXPRESSION; HEART MUSCLE ISCHEMIA; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; INFLAMMATION; LEG ISCHEMIA; LYMPHOCYTE DIFFERENTIATION; MAGNETISM; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PERFUSION; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; QUANTITATIVE STUDY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEPARATION TECHNIQUE; SURGICAL TECHNIQUE; T LYMPHOCYTE; UPREGULATION; ANGIOGENESIS; ANIMAL; BIOSYNTHESIS; HINDLIMB; ISCHEMIA; METABOLISM; MONONUCLEAR CELL; NUDE MOUSE; PHYSIOLOGY; TRANSPLANTATION; UMBILICAL VEIN ENDOTHELIAL CELL; VASCULARIZATION;

ANIMALS; ANTIGENS, CD31; CELLS, CULTURED; HINDLIMB; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; ISCHEMIA; LEUKOCYTES, MONONUCLEAR; MICE; MICE, NUDE; NEOVASCULARIZATION, PHYSIOLOGIC;

EID: 84893515683     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2011.11.097     Document Type: Article

References (33)

1. Carmeliet P. Angiogenesis in health and disease. Nat Med 2003; 9: 653-60.
2. Asahara T, Murohara T, Sullivan A, et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997; 275: 964-7.
3. Bhattacharya V, McSweeney PA, Shi Q, et al. Enhanced endothelialization and microvessel formation in polyester grafts seeded with CD34(+) bone marrow cells. Blood 2000; 95: 581-5.
4. Orlic D, Kajstura J, Chimenti S, et al. Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proc Natl Acad Sci U S A 2001; 98: 10344-9.
5. Hur J, Yoon CH, Kim HS, et al. Characterization of two types of endothelial progenitor cells and their different contributions to neovasculogenesis. Arterioscler Thromb Vasc Biol 2004; 24: 288-93.
6. Kalka C, Masuda H, Takahashi T, et al. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci U S A 2000; 97: 3422-7.
7. Ingram DA, Caplice NM, Yoder MC Unresolved questions, changing definitions, and novel paradigms for defining endothelial progenitor cells. Blood 2005; 106: 1525-31.
8. Gao D, Nolan DJ, Mellick AS, Bambino K, McDonnell K, Mittal V. Endothelial progenitor cells control the angiogenic switch in mouse lung metastasis. Science 2008; 319: 195-8.
9. Gulati R, Jevremovic D, Peterson TE, et al. Diverse origin and function of cells with endothelial phenotype obtained from adult human blood. Circ Res 2003; 93: 1023-5.
10. Rehman J, Li J, Orschell CM, March KL Peripheral blood "endothelial progenitor cells" are derived from monocyte/macrophages and secrete angiogenic growth factors. Circulation 2003; 107: 1164-9.
11. Lin Y, Weisdorf DJ, Solovey A, Hebbel RP. Origins of circulating endothelial cells and endothelial outgrowth from blood. J Clin Invest 2000; 105: 71-7.
12. Ingram DA, Mead LE, Tanaka H, et al. Identification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood. Blood 2004; 104: 2752-60.
13. Shantsila E, Lip GY. Circulating endothelial cells in health and disease: how do we best quantify them? J Thromb Haemost 2008; 6: 1021-4.
14. Schmidt-Lucke C, Fichtlscherer S, Aicher A, Tschope C, Schultheiss HP, Zeiher AM, et al. Quantification of circulating endothelial progenitor cells using the modified ISHAGE protocol. PLoS One 2010; 5:e13790.
15. Steinmetz M, Nickenig G, Werner N. Endothelial-regenerating cells: an expanding universe. Hypertension 2010; 55: 593-9.
16. Newman PJ, Berndt MC, Gorski J, et al. PECAM-1 (CD31) cloning and relation to adhesion molecules of the immunoglobulin gene superfamily. Science 1990; 247: 1219-22.
17. Newman PJ, Newman DK. Signal transduction pathways mediated by PECAM-1: new roles for an old molecule in platelet and vascular cell biology. Arterioscler Thromb Vasc Biol 2003; 23: 953-64.
18. + cells have robust angiogenic and vasculogenic properties and are effective for treating ischemic vascular disease. J Am Coll Cardiol 2010; 56: 593-607.
19. Asahara T, Takahashi T, Masuda H, et al. VEGF contributes to postnatal neovascu-larization by mobilizing bone marrow-derived endothelial progenitor cells. EMBO J 1999; 18: 3964-72.
20. Cho HJ, Lee N, Lee JY, et al. Role of host tissues for sustained humoral effects after endothelial progenitor cell transplantation into the ischemic heart. J Exp Med 2007; 204: 3257-69.
21. Yoon YS, Wecker A, Heyd L, et al. Clonally expanded novel multipotent stem cells from human bone marrow regenerate myocardium after myocardial infarction. J Clin Invest 2005; 115: 326-38.
22. Bonauer A, Carmona G, Iwasaki M, et al. MicroRNA-92a controls angiogenesis and functional recovery of ischemic tissues in mice. Science 2009; 324: 1710-3.
23. Shake JG, Gruber PJ, Baumgartner WA, et al. Mesenchymal stem cell implantation in a swine myocardial infarct model: engraftment and functional effects. Ann Thorac Surg 2002; 73: 1919-25 [discussion 26].
24. Toma C, Pittenger MF, Cahill KS, Byrne BJ, Kessler PD. Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation 2002; 105: 93-8.
25. Miyamoto K, Nishigami K, Nagaya N, et al. Unblinded pilot study of autologous transplantation of bone marrow mononuclear cells in patients with thromboangiitis obliterans. Circulation 2006; 114: 2679-84.
26. Yoon YS, Park JS, Tkebuchava T, Luedeman C, Losordo DW. Unexpected severe calcification after transplantation ofbone marrow cells in acute myocardial infarction. Circulation 2004; 109: 3154-7.
27. George J, Afek A, Abashidze A, et al. Transfer of endothelial progenitor and bone marrow cells influences atherosclerotic plaque size and composition in apolipo-protein E knockout mice. Arterioscler Thromb Vasc Biol 2005; 25: 2636-41.
28. Aranguren XL, McCue JD, Hendrickx B, et al. Multipotent adult progenitor cells sustain function of ischemic limbs in mice. J Clin Invest 2008; 118: 505-14.
29. Balkwill F. TNF-alpha in promotion and progression of cancer. Cancer Metastasis Rev 2006; 25: 409-16.
30. Bogen S, Pak J, Garifallou M, Deng X, Muller WA. Monoclonal antibody to murine PECAM-1 (CD31) blocks acute inflammation in vivo. J Exp Med 1994; 179: 1059-64.
31. Ozaki H, Ishii K, Horiuchi H, et al. Cutting edge: combined treatment of TNF-alpha and IFN-gamma causes redistribution of junctional adhesion molecule in human endothelial cells. J Immunol 1999; 163: 553-7.
32. Murohara T, Asahara T, Silver M, et al. Nitric oxide synthase modulates angiogenesis in response to tissue ischemia. J Clin Invest 1998; 101: 2567-78.
33. Limaye V, Li X, Hahn C, et al. Sphingosine kinase-1 enhances endothelial cell survival through a PECAM-1-dependent activation of PI-3K/Akt and regulation of Bcl-2 family members. Blood 2005; 105: 3169-77.